KCNJ11 and Alzheimer disease: Further enhancing the sensitivity of some of the current biomarkers, present in both CSF and blood, including extracellular vesicles displaying markers for BIR, would also aid in tracking the progression of BIR alongside other pathological hallmarks of AD.